Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cellular Injury II: Classification01:21

Cellular Injury II: Classification

Cellular injury is any process that disrupts a cell’s ability to maintain homeostasis, leading to structural or functional changes. It is broadly classified based on etiology (cause) and mechanism of damage.Classification by EtiologyCellular injury may result from several causes. Hypoxic injury happens due to reduced oxygen delivery, most commonly from inadequate blood supply, such as arterial obstruction; for example, coronary artery thrombosis can cause myocardial infarction. Chemical injury...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Natural History of Patients With Histologically Proven Acute Eosinophilic Myocarditis.

Circulation·2026
Same author

[[The Observational Study]].

Acta gastroenterologica Latinoamericana·2025
Same author

On multiple comparisons and competitive variables.

Archivos argentinos de pediatria·2025
Same author

[Double-chambered right ventricle in a patient with hypertrophic cardiomyopathy. A case report].

Archivos peruanos de cardiologia y cirugia cardiovascular·2025
Same author

Significant tricuspid regurgitation is associated with adverse outcomes in patients with transthyretin amyloid cardiomyopathy.

Archivos peruanos de cardiologia y cirugia cardiovascular·2024
Same author

Comparison of clinical outcomes of venous thromboembolic disease between outpatient and inpatient management.

Archivos peruanos de cardiologia y cirugia cardiovascular·2024

Related Experiment Video

Updated: Jun 5, 2026

Developing a Clinically Relevant Hemorrhagic Shock Model in Rats
08:14

Developing a Clinically Relevant Hemorrhagic Shock Model in Rats

Published on: March 22, 2024

Mixed shock: from pathophysiology to clinical practice.

Arturo Miguel Cagide1, Ignacio Martín Bluro1, Aníbal Martín Arias1

  • 1Servicio de Cardiología, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina. Servicio de Cardiología Hospital Italiano de Buenos Aires Ciudad Autónoma de Buenos Aires Argentina.

Archivos Peruanos De Cardiologia Y Cirugia Cardiovascular
|June 4, 2026
PubMed
Summary
This summary is machine-generated.

Mixed shock, a complex hemodynamic condition, involves impaired contractility and vasoplegia. Effective management requires integrating hemodynamic correction with bedside assessment and tailored pharmacologic strategies.

Keywords:
Heart FailureShockVasodilation

More Related Videos

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
16:31

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Published on: June 6, 2011

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Related Experiment Videos

Last Updated: Jun 5, 2026

Developing a Clinically Relevant Hemorrhagic Shock Model in Rats
08:14

Developing a Clinically Relevant Hemorrhagic Shock Model in Rats

Published on: March 22, 2024

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
16:31

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Published on: June 6, 2011

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Hemodynamics

Background:

  • Mixed shock presents a complex hemodynamic challenge, often evolving from or coexisting with cardiogenic and distributive shock.
  • Neurohormonal activation is a common factor, exacerbating fluid retention and circulatory dysfunction in shock states.
  • Distinguishing between shock types can be difficult due to overlapping pathophysiological mechanisms and temporal dynamics.

Purpose of the Study:

  • To elucidate the complex pathophysiology of mixed shock.
  • To outline a strategic approach for the clinical recognition and management of mixed shock.
  • To emphasize the importance of integrating hemodynamic assessment with clinical judgment.

Main Methods:

  • Review of pathophysiological mechanisms underlying mixed shock.
  • Analysis of clinical presentation and diagnostic challenges.
  • Discussion of evidence-based management strategies, including goal-directed therapy and pharmacologic interventions.

Main Results:

  • Mixed shock is characterized by a variable interplay of reduced myocardial contractility and vasoplegia.
  • Successful management hinges on continuous bedside assessment of tissue perfusion and goal-directed hemodynamic correction.
  • Pharmacological choices must consider the combined effects on contractility and vascular tone.

Conclusions:

  • Clinical recognition of mixed shock requires careful consideration of evolving hemodynamic profiles.
  • An integrated approach combining hemodynamic monitoring, perfusion assessment, and judicious pharmacotherapy is crucial.
  • Sound clinical judgment, based on a deep understanding of shock pathophysiology, remains paramount for optimal patient outcomes.